Newborn BCG vaccination complemented by boosting correlates better with reduced juvenile diabetes in females, than vaccination alone

Vaccine ◽  
2020 ◽  
Vol 38 (41) ◽  
pp. 6427-6434
Author(s):  
Benjamin Y. Klein
PsycCRITIQUES ◽  
1987 ◽  
Vol 32 (9) ◽  
Author(s):  
No authorship indicated
Keyword(s):  

1974 ◽  
Vol 75 (1) ◽  
pp. 50-63 ◽  
Author(s):  
Kristian F. Hanssen

ABSTRACT Twenty newly diagnosed, but as yet untreated patients of both sexes with classical juvenile diabetes were investigated by determining the mean plasma immunoreactive growth hormone (IRHGH) and urinary IRHGH for a 24 hour period before and during initial insulin treatment. The plasma IRHGH was significantly higher (0.05 > P > 0.01) before than during initial insulin treatment. During initial insulin treatment, the mean plasma IRHGH was significantly higher (0.01 > P > 0.001) than in a control group. The urinary IRHGH was significantly higher (0.01 > P > 0.001) before than during insulin treatment. The increased urinary IRHGH observed before insulin treatment is thought to be partly due to a defective renal tubular reabsorption of growth hormone. No significant correlation was found between the mean blood sugar and plasma or urinary IRHGH either before or during insulin treatment.


1959 ◽  
Vol XXXI (II) ◽  
pp. 241-260 ◽  
Author(s):  
C. A. Hernberg ◽  
G. af Björkesten ◽  
S. Vannas
Keyword(s):  

1959 ◽  
Vol XXXII (IV) ◽  
pp. 491-496 ◽  
Author(s):  
Robert S. Walker ◽  
Adam L. Linton

ABSTRACT A brief comparison of phenethyl-biguanide (D. B. I.) with other oral hypoglycaemic drugs is made. A series of 31 juvenile diabetics treated with D. B. I. is described, and the reasons for partial success or failure are considered. The advantages and dangers of the drug are discussed. It is concluded that the unique action of this drug may give it a place in the treatment of juvenile diabetes.


Diabetes ◽  
1976 ◽  
Vol 25 (5) ◽  
pp. 420-427 ◽  
Author(s):  
F. M. Bomback ◽  
S. Nakagawa ◽  
S. Kumin ◽  
H. M. Nitowsky

Author(s):  
Sujatha S. ◽  
Rebecca Samson ◽  
Christopher Amalraj ◽  
Sundaresan Sundaresan

Neglected pain in neonates leads to various ill effects and it can be prevented by using simple and safe non-pharmacological pain relieving measures. Pharmacologic agents are not recommended in neonates for acute pain due toinvasive procedures however, administration of 24% oralsucrose solutionis found to be effective. The objective of this study was to assess the efficacy of 24%oral sucrose in combination with Facilitated tucking during BCG Vaccination through intradermalroute in term neonates which is not done elsewhere. Fifty five healthy term neonates who fulfilled the inclusion criteria such as gestational age above 37 weeks, within 24 hoursof birth age, and neonates delivered only through spontaneous vaginal delivery were included in the study. The study intervention consists of administration of 2 ml of oral 24% sucrose 2 minutes before BCG Vaccination through intradermal route and Facilitated tuckingat the time of vaccination. The primary outcome measure of cumulative NIPS score at 0, 3,5 minuteswas not significant in both the study groups. Whereas there was significant reduction in the level of pain and mean cry time in the neonates of sucrose group. Heart rateand oxygen saturation after intradermal injection also showed significant (p less than 0.001) differenceamong the neonates, who received 24% of oral sucroseand Facilitated tucking than for neonates of control group. Thus oral (24%)sucrose solution given 2 minutes before injection was effective in reducing level of neonatal pain following Intradermal Vaccination. It is a simple, safe and fast acting analgesic and should be considered for minor invasive procedures in term neonates which last for 5-7minutes.


Sign in / Sign up

Export Citation Format

Share Document